Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Currently, research on GLP-1 agonists during pregnancy is limited, and most guidelines recommend against their use while pregnant due to potential unknown effects on fetal development
10.1371/journal.pone.0192441 224
Causes and Management Some patients taking GLP-1 receptor agonists for type 2 diabetes or weight management report changes in sweating patterns, prompting questions about whether these medications directly cause increased perspiration
Through our telehealth platform, you can complete a free assessment quiz to share your health history and goals
US$ 28.01
US$ 23.69
US$ 29.50
US$ 28.47
